Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia

Clinical trial NCT07485283 · RECRUITING

Trial details

NCT number: NCT07485283
Sponsor: Tor Biering-Sørensen
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiovascular Disease Dementia

Start date: 2026-04-28
Primary completion: 2029-04-01
Enrollment: 162000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.